Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Kenvue
KVUE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$161M |
| 3 |
Extra Space Storage
EXR
|
$134M |
| 4 |
GE HealthCare
GEHC
|
$113M |
| 5 |
Ferguson
FERG
|
$97.1M |
Top Sells
| 1 |
PDCE
PDC Energy, Inc.
PDCE
|
$313M |
| 2 |
Super Micro Computer
SMCI
|
$305M |
| 3 |
UNVR
Univar Solutions Inc.
UNVR
|
$176M |
| 4 |
LSI
Life Storage, Inc.
LSI
|
$160M |
| 5 |
Walmart
WMT
|
$112M |
Sector Composition
| 1 | Technology | 17.36% |
| 2 | Financials | 16.12% |
| 3 | Industrials | 13.02% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Healthcare | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Sera Prognostics
SERA
$129M
| $27.9K | ﹤0.01% |
14,979
-4,942
| -25% | -$9.19K |
|
3427
Glimpse Group
VRAR
$29.9M
| $26.6K | ﹤0.01% |
+14,436
| New | +$26.6K |
|
3428
Cartesian Therapeutics
RNAC
$267M
| $25.6K | ﹤0.01% |
804
| – | – |
|
|
CELL
3429
DELISTED
PhenomeX Inc. Common Stock
CELL
| $25.5K | ﹤0.01% |
25,591
| – | – |
|
3430
Inovio Pharmaceuticals
INO
$144M
| $25.3K | ﹤0.01% |
5,419
-657
| -11% | -$3.07K |
|
3431
Virgin Galactic
SPCE
$177M
| $24.9K | ﹤0.01% |
692
-4,353
| -86% | -$157K |
|
|
IPM
3432
Intelligent Protection Management Corp. Common Stock
IPM
$25.3M
| $24.9K | ﹤0.01% |
13,742
+8
| +0.1% | +$14 |
|
3433
AmpliTech
AMPG
$81.7M
| $24.3K | ﹤0.01% |
11,861
-11,408
| -49% | -$23.4K |
|
3434
BlackSky Technology
BKSY
$583M
| $24.3K | ﹤0.01% |
+2,592
| New | +$24.3K |
|
3435
Worksport
WKSP
$25.3M
| $24.1K | ﹤0.01% |
+1,146
| New | +$24.1K |
|
3436
Protara Therapeutics
TARA
$125M
| $23.1K | ﹤0.01% |
13,821
-4,931
| -26% | -$8.24K |
|
3437
SCYNEXIS
SCYX
$35.2M
| $22.8K | ﹤0.01% |
+10,009
| New | +$22.8K |
|
3438
Compass Therapeutics
CMPX
$466M
| $22K | ﹤0.01% |
11,161
-19,289
| -63% | -$38K |
|
|
CASA
3439
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $22K | ﹤0.01% |
25,906
-31,753
| -55% | -$26.9K |
|
3440
Corvus Pharmaceuticals
CRVS
$419M
| $21.7K | ﹤0.01% |
14,890
-43,222
| -74% | -$63.1K |
|
3441
Instil Bio
TIL
$196M
| $21.5K | ﹤0.01% |
2,525
| – | – |
|
|
IAUX
3442
i-80 Gold Corp
IAUX
$662M
| $21.5K | ﹤0.01% |
+14,032
| New | +$21.5K |
|
3443
Lyell Immunopharma
LYEL
$220M
| $19.8K | ﹤0.01% |
673
| – | – |
|
3444
Cardiff Oncology
CRDF
$130M
| $19.7K | ﹤0.01% |
14,206
-17,093
| -55% | -$23.8K |
|
|
CGC
3445
Canopy Growth
CGC
$437M
| $18.6K | ﹤0.01% |
2,377
-50,644
| -96% | -$396K |
|
3446
Allbirds
BIRD
$51.7M
| $18K | ﹤0.01% |
810
| – | – |
|
3447
Fuel Tech
FTEK
$88.9M
| $17.3K | ﹤0.01% |
14,677
| – | – |
|
|
KNTE
3448
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $17.1K | ﹤0.01% |
12,249
-13,335
| -52% | -$18.6K |
|
3449
Kartoon Studios
TOON
$39.8M
| $16.4K | ﹤0.01% |
11,631
-15,063
| -56% | -$21.2K |
|
|
DMTK
3450
DELISTED
DermTech, Inc. Common Stock
DMTK
| $15K | ﹤0.01% |
10,438
-21,494
| -67% | -$31K |
|